CanSino Biologics Valuation
| CJH Stock | 2.36 0.12 4.84% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. CanSino Biologics shows a prevailing Real Value of USD1.93 per share. The current price of the firm is USD2.36. Our model approximates the value of CanSino Biologics from analyzing the firm fundamentals such as Shares Owned By Insiders of 26.70 %, current valuation of 3.4 B, and Return On Equity of 0.0111 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CanSino Biologics' price fluctuation is dangerous at this time. Calculation of the real value of CanSino Biologics is based on 3 months time horizon. Increasing CanSino Biologics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for CanSino Biologics is useful when determining the fair value of the CanSino stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of CanSino Biologics. Since CanSino Biologics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CanSino Stock. However, CanSino Biologics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.36 | Real 1.93 | Hype 2.36 | Naive 2.35 |
The real value of CanSino Stock, also known as its intrinsic value, is the underlying worth of CanSino Biologics Company, which is reflected in its stock price. It is based on CanSino Biologics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of CanSino Biologics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CanSino Biologics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CanSino Biologics helps investors to forecast how CanSino stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CanSino Biologics more accurately as focusing exclusively on CanSino Biologics' fundamentals will not take into account other important factors: CanSino Biologics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining CanSino Biologics's current stock value. Our valuation model uses many indicators to compare CanSino Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CanSino Biologics competition to find correlations between indicators driving CanSino Biologics's intrinsic value. More Info.CanSino Biologics is rated below average in price to book category among related companies. It is rated below average in price to sales category among related companies fabricating about 0.97 of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for CanSino Biologics is roughly 1.04 . Comparative valuation analysis is a catch-all model that can be used if you cannot value CanSino Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CanSino Biologics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CanSino Biologics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CanSino Biologics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CanSino Biologics and how it compares across the competition.
About CanSino Biologics Valuation
The stock valuation mechanism determines the current worth of CanSino Biologics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of CanSino Biologics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CanSino Biologics based exclusively on its fundamental and basic technical indicators. By analyzing CanSino Biologics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of CanSino Biologics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CanSino Biologics. We calculate exposure to CanSino Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CanSino Biologics's related companies.8 Steps to conduct CanSino Biologics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CanSino Biologics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CanSino Biologics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain CanSino Biologics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CanSino Biologics' revenue streams: Identify CanSino Biologics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CanSino Biologics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish CanSino Biologics' growth potential: Evaluate CanSino Biologics' management, business model, and growth potential.
- Determine CanSino Biologics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CanSino Biologics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CanSino Biologics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for CanSino Stock analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |